NIH-funded research R21 grant

Creating a sensor to measure GABA levels in the brain

Official title: Engineered GABA oxidase for GABA sensing in vivo

Funded at University of California Los Angeles · NIH-10953239 · Data updated 2026-11-12

This study is working on a new sensor that can track GABA levels in the brain in real-time, which could help people with conditions like Alzheimer's and autism by giving us better insights into how their brains are functioning.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJuly 15, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$388,158
NIH project number1R21NS139078-01
Project IDNIH-10953239 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with neurological disorders such as Alzheimer's disease, autism, or epilepsy.

Less likely to help

Patients without neurological disorders or those not affected by GABA dysregulation may not benefit from this research.

What this research studies

This research focuses on developing a specialized sensor that can measure levels of GABA, an important neurotransmitter, in real-time within the brain. The approach involves engineering a GABA oxidase enzyme that can produce a measurable signal when GABA is present, allowing for precise monitoring of its levels. This technology aims to address the current limitations in tracking GABA dynamics, particularly in conditions like Alzheimer's disease and autism, where GABA regulation is crucial. By implanting this sensor, researchers hope to gain insights into brain function and neurotransmitter balance.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and management of neurological conditions associated with GABA dysregulation.

How similar studies have gone: While the approach of using enzyme-based sensors is established, the specific application for GABA monitoring in vivo is relatively novel and has not been extensively tested.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Monbouquette, Harold George — University of California Los Angeles
  • Study coordinator: Monbouquette, Harold George

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.